Astellas Pharma Inc.  _ Annual Report 2014 168 Astellas conducted a five-for-one stock split on April 1, 2014. As a result, authorized common stock and issued common stock increased to 9,000,000,000 shares and 2,284,823,175 shares, respectively. Company Name Head Office Capital (as of March 31, 2014) Representative Founded Professional Institution Affiliation Stock Exchange Listing Independent Auditors Common Stock (as of March 31, 2014) Number of shareholders: 45,857 Astellas Pharma Inc. 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8411, Japan TEL: +81-3-3244-3000 http://www.astellas.com/en/ ¥103 billion yoshihiko Hatanaka Representative Director, President and CEO 1923 International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) * Masafumi Nogimori (Representative Director and Chairman) was appointed  Vice President of the IFPMA in November 2010. Tokyo (Securities Code: 4503) Ernst & young ShinNihon LLC Hibiya Kokusai Building, 2-2-3 Uchisaiwai-cho, Chiyoda-ku, Tokyo 100-0011, Japan Authorized: 2,000,000,000 Issued:   456,964,635 (including 10,736,279 treasury stock) corporate Data/investor inforMation